Senators Shaheen and Hassan Reintroduce $65 Billion Turn the Tide Act to Combat Substance Use Disorder

As the nation records its third consecutive year of declining overdose deaths, two New Hampshire senators are pushing to cement those gains with a massive federal investment that would reshape how the United States funds addiction treatment and prevention for the next decade.

U.S. Senators Jeanne Shaheen and Maggie Hassan, both Democrats from New Hampshire, reintroduced the Turn the Tide Act this week, legislation that would authorize more than $65 billion in federal funding over ten years to combat substance use disorder. The bill arrives at a pivotal moment: while national overdose deaths fell 14% in 2025, an estimated 45,000 Americans still lost their lives to opioid-involved overdoses last year.

"Substance use disorder impacts communities in every corner of our state, and I've heard from countless families who have been torn apart by this crisis," Shaheen said in a statement announcing the reintroduction. The senior member of the Senate Appropriations Committee emphasized that despite progress, long-term investments remain essential to sustaining the fight against addiction.

Hassan echoed that sentiment, noting that while New Hampshire has made important strides in reducing overdose deaths, "the fentanyl crisis continues to devastate families across our state. We cannot let up now."

A Comprehensive Funding Framework

The Turn the Tide Act represents one of the most ambitious federal funding proposals for addiction services in recent memory. At its core, the legislation would dramatically expand the State Opioid Response (SOR) grant program, increasing its annual funding to $5.5 billion—a nearly fourfold increase from current levels. These grants serve as the backbone of state-level addiction responses, supporting everything from medication-assisted treatment expansion to naloxone distribution programs.

The bill's funding architecture extends well beyond SOR grants. The legislation would establish new dedicated funding streams for workforce development, recognizing that provider shortages remain one of the most stubborn barriers to treatment access. According to Health Resources and Services Administration data cited in the bill's framework, the United States currently faces a shortfall of approximately 77,050 addiction counselors and 99,780 mental health counselors—gaps that leave millions of Americans unable to access evidence-based care even when they seek it.

Prevention programs would receive significant new resources under the proposal, with funding targeted at school-based interventions, community outreach, and early identification initiatives. The bill acknowledges a growing consensus among public health researchers: that effective addiction policy must address substance use before it escalates to dependency, particularly among adolescents whose developing brains face heightened vulnerability.

Addressing the Workforce Crisis

Perhaps the most distinctive element of the Turn the Tide Act is its explicit focus on workforce expansion. The legislation would create new training pipelines for addiction medicine providers, fund loan repayment programs for professionals working in underserved areas, and support the development of paraprofessional roles that could extend the reach of limited specialist capacity.

This workforce emphasis reflects a hard-learned lesson from the past decade of addiction policy. Despite the elimination of the X-waiver requirement for buprenorphine prescribing and the expansion of telehealth flexibilities, millions of Americans with opioid use disorder remain untreated—not because they lack insurance coverage or because medications are unavailable, but because there simply aren't enough providers to meet demand.

Rural communities face particularly acute shortages. In many Appalachian and Midwestern counties, the nearest addiction specialist may be hours away, creating what researchers have termed a "distance death sentence"—the correlation between geographic isolation from treatment and dramatically elevated overdose mortality. The Turn the Tide Act would direct specific funding toward training providers in these underserved regions and supporting telehealth infrastructure that can bridge geographic gaps.

The Political Landscape

The reintroduction comes amid an uncertain federal policy environment. The Trump administration has sent mixed signals on addiction funding, simultaneously announcing new investments through the Great American Recovery Initiative while implementing political review processes that have delayed billions in congressionally approved HHS grants. An AI screening system now flags applications containing terms like "harm reduction" and "gender" before they advance to human review, creating unprecedented backlogs.

The Turn the Tide Act's bipartisan framing—Hassan described it as "bipartisan" in her statement—suggests an attempt to build broad support that could survive potential shifts in administration priorities. The bill's emphasis on treatment access and workforce development aligns with priorities that have historically drawn support from both parties, even as debates over harm reduction strategies have grown more polarized.

Whether the legislation can advance in a closely divided Congress remains unclear. The $65 billion price tag, while spread over a decade, represents a significant expansion of federal addiction spending. Proponents will need to demonstrate that the investment would produce measurable returns in reduced mortality, decreased healthcare costs, and improved public safety outcomes.

Building on Momentum

The timing of the reintroduction reflects a strategic calculation: with overdose deaths declining nationally for the first sustained period in years, policymakers have a narrow window to institutionalize the interventions that appear to be working. The 14% national reduction in overdose deaths in 2025, following similar declines in 2023 and 2024, has created rare bipartisan momentum around addiction policy.

New Hampshire itself offers a case study in what's possible with sustained investment. The state has seen overdose deaths fall dramatically from their peak, driven by a combination of Medicaid expansion, harm reduction infrastructure, and treatment access improvements. Shaheen and Hassan are effectively arguing that the federal government should scale the New Hampshire model nationwide—and provide the long-term funding stability that would allow other states to build similarly comprehensive systems.

The Turn the Tide Act would also support the integration of addiction treatment into mainstream healthcare settings, funding initiatives that embed substance use disorder services within primary care practices, emergency departments, and correctional facilities. This integration approach reflects growing recognition that addiction cannot be effectively addressed through siloed specialty programs alone; rather, it requires meeting patients where they already seek care.

Looking Forward

For the millions of Americans living with substance use disorders, the Turn the Tide Act represents a potential lifeline—if it can navigate the legislative process. The bill's ten-year funding horizon would provide unprecedented stability for treatment providers, allowing them to invest in infrastructure and workforce development with confidence that federal support won't evaporate with the next budget cycle or administration transition.

As Congress considers the proposal, the 45,000 Americans who died from opioid overdoses in 2025 serve as a stark reminder of what's at stake. The decline in deaths is real and worth celebrating, but it remains fragile—threatened by an evolving drug supply, emerging synthetic opioids, and the persistent barriers that prevent so many from accessing life-saving treatment.

Shaheen and Hassan are betting that Congress is ready to move beyond crisis response toward sustained investment. The Turn the Tide Act offers a roadmap for what that investment could look like: comprehensive, workforce-focused, and designed for the long haul. Whether lawmakers will follow that roadmap remains the open question that will shape addiction policy for years to come.